Bioculture (Mauritius) Ltd is the founding company of the Bioculture Group, a world leader in the ethical breeding and export of Specific Pathogen Free (SPF) cynomolgus macaques (Macaca fascicularis) for biomedical research.
Founded in 1985 by Mary-Ann and Owen Griffiths
Bioculture (Mauritius) Ltd was established to create an ethical, sustainable, and scientifically reliable source of NHPs for global biomedical research. The company pioneered SPF breeding in the Indian Ocean region, combining animal welfare principles with genetic management and veterinary excellence.
Bioculture Mauritius serves as the Group’s core breeding and export center, ensuring the highest welfare, health, and traceability standards across every animal destined for research.
Its operations form the first phase of the Group’s Care to Cure value chain, connecting responsible breeding with the scientific needs of U.S. and international research institutions.
Located in a secure, environmentally managed area of Mauritius, the company’s facilities include SPF colonies, quarantine zones, veterinary laboratories & behavioral enrichment units designed for animal health, socialization & biosecurity.
Bioculture Mauritius specializes in breeding SPF cynomolgus macaques for use in biomedical and pharmaceutical research.
Animals are housed in social groups, raised under welfare-focused husbandry & supported by data driven management.
Multiple independent units preventing cross-contamination.
Controlled environments for animal development and acclimation.
Equipped for diagnostics, pathology, and health monitoring.
Secure holding areas for pre-export preparation and welfare review.
Bioculture Mauritius operates under stringent international welfare and research standards to ensure consistency, credibility, and ethical assurance.
For NHP supply inquiries, compliance documentation, or partnership discussions, please contact our Mauritius office directly.